Blue Jet Healthcare Limited (BOM:544009)

Market Cap	68.92B -30.4%
Revenue (ttm)	11.79B +63.3%
Net Income	3.52B +109.9%
EPS	20.31 +109.8%
Shares Out	n/a
PE Ratio	19.56
Forward PE	20.42
Dividend	1.20 (0.27%)
Ex-Dividend Date	Sep 19, 2025

Volume	42,350
Average Volume	19,743
Open	436.70
Previous Close	441.60
Day's Range	397.45 - 443.85
52-Week Range	393.00 - 1,028.20
Beta	n/a
RSI	31.48
Earnings Date	Feb 2, 2026

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Pharmaceutical Preparations
• Founded: 1968
• Employees: 196
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544009

Financial Performance

In fiscal year 2025, Blue Jet Healthcare's revenue was 10.30 billion, an increase of 44.74% compared to the previous year's 7.12 billion. Earnings were 3.05 billion, an increase of 86.38%.